Leading International Vaccinology Education for Innovation

LIVE_Innov, the Erasmus Mundus Joint Master “Leading International Vaccinology Education for Innovation” welcomes motivated Scientists, Bioeng, Clinicians, PharmD and Vet, with at least a BSc level in cell/mol biol, biochem, microbio, physio and immuno-logy to educate them into skilled vaccinologists adapted to our changing world. LIVE_Innov is a 2-year MSc in Biomedical Sc with multidisciplinary sciences and humanities (https://masterlive-vaccinology.eu/) awards 120 ECTS in vaccine research, design, innovation, preclinical and clinical development to scale-up, produce with quality, managing regulatory affairs, communicating on vaccines & public health, fostering access to safe existing and new vaccines, understanding health economics pillars, fighting epipandemics to ensure that vaccines save more lives. LIVE_Innov is jointly produced by 5 leading universities with semester 1 (S1) jointly at Universitat Autònoma de Barcelona and Universitat de Barcelona (ES), S2 at Universiteit Antwerpen (BE), S3 jointly at Université Jean Monnet Saint-Etienne and Université Claude Bernard Lyon 1 (FR), in agreement and close collaboration with 61 associated partners (AP) from 23 countries. LIVE APs cover the vaccinology work chain to host 30+ students a year for their S4 6- month professional internship in academia or private institutions promoting internationality, creativity and employability.
LIVE_Innov will educate 120+ vaccinologists of 50+ nationalities by 2029, connected to the growing LIVE Alumni family, to tackle challenges for developing prophylactic and therapeutic vaccines, being involved in "Reality projects" in research, training, communication and innovation. LIVE_Innov takes care of our changing world by imagining future vaccines, lowering negative impacts of Anthropocene: from efficient "green" production and administration of vaccines to future adaptive vaccinology quickly dealing with climate change-induced emerging diseases and benefiting from AI for innovation.